cancer is the most common cause of cancer death for both men and women
in the United States, and it is a growing worldwide problem, especially
in developing countries. In the past, there were few good options for
the early detection, prevention, or treatment of lung cancer. This led
to considerable pessimism regarding the care of patients with the
disease. In the recent past, however, there have been many
advances in the biology, early detection, staging, prevention, and
treatment of lung cancer that are bringing about a reassessment of the
nihilistic attitude of physicians toward lung cancer patients. For the
optimal care of lung cancer patients, these advances require a
multimodality approach to detection, staging, prevention, and therapy.
These advances are summarized in this supplement, based on the
proceedings of the Multimodality Approach to Lung Cancer symposium,
held in Vail, Colorado.